TORONTO, April 27,
2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX:
DHT.U) ("DRI" or "the Trust") announced today that it will hold a
conference call to discuss its first quarter financial results on
Friday, May 12, 2023, at 8:00 a.m. ET. The Trust will report its financial
results on Thursday, May 11, 2023,
after market close.
All interested parties may join the conference call by dialling
416-764-8659 or 1-888-664-6392 approximately 15 minutes prior to
the call to secure a line. You will be put on hold until the
conference call begins. A question-and-answer session will follow
the conference call, at which time the operator will provide
instructions for submitting questions.
A live webcast of the conference call, including a slide
presentation, will be available at
https://app.webinar.net/dYlZQRq154e. Please connect at least 15
minutes prior to the conference call to ensure adequate time for
any software download that may be required to join the webcast. The
webcast will be archived on the Trust's website following the call
date.
About DRI Healthcare
Trust
DRI Healthcare Trust is managed by DRI Capital Inc. ("DRI
Capital"), the pioneer in global pharmaceutical royalty
monetization with a more than 30-year history of accelerating
innovation by providing capital to inventors, academic institutions
and biopharma companies. Since our founding in 1989, DRI Capital
has deployed more than US$2.5
billion, acquiring more than 70 royalties on 40-plus drugs,
including Eylea, Spinraza, Zytiga, Remicade, Keytruda and Stelara.
DRI Healthcare Trust's units are listed and trade on the Toronto
Stock Exchange in Canadian dollars under the symbol "DHT.UN" and in
US dollars under the symbol "DHT.U". To learn more, visit
drihealthcare.com or follow us on LinkedIn.
SOURCE DRI Healthcare Trust